UK markets closed

AlzeCure Pharma AB (publ) (AC6.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.1300+0.0095 (+7.88%)
At close: 09:15AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
27,594
27,707
46,183
66,715
62,356
Selling general and administrative
10,831
10,598
10,168
11,265
9,375
Total operating expenses
38,580
38,344
56,569
78,143
72,022
Operating income or loss
-38,580
-38,344
-56,569
-78,143
-72,022
Interest expense
8
7
4
1
1
Income before tax
-37,426
-37,167
-56,239
-77,781
-71,366
Income from continuing operations
-37,426
-37,167
-56,239
-77,781
-71,366
Net income
-37,426
-37,167
-56,239
-77,781
-71,366
Net income available to common shareholders
-37,426
-37,167
-56,239
-77,781
-71,366
Basic EPS
-0.65
-
-1.05
-1.83
-1.61
Diluted EPS
-0.65
-
-1.05
-1.83
-1.61
Basic average shares
59,249
-
53,822
42,616
44,365
Diluted average shares
59,324
-
54,223
43,079
44,700